Literature DB >> 12039408

Relevance of KIR gene polymorphisms in bone marrow transplantation outcome.

Katia Gagne1, Géraldine Brizard, Brigitte Gueglio, Noël Milpied, Patricia Herry, Françoise Bonneville, Mary Luce Chéneau, Nicolas Schleinitz, Anne Cesbron, Gilles Folléa, Jean Luc Harrousseau, Jean Denis Bignon.   

Abstract

Natural Killer (NK) cells may be involved both in allogeneic bone marrow transplantation (BMT) rejection and graft-versus-host disease (GVHD). The physiologic functions of NK cells appear to be regulated by diverse non-inhibitory and inhibitory receptors including the killer cell immunoglobulin-like receptors (KIR). Although human leukocyte antigen (HLA) epitope mismatches are well-known causes of NK alloreactivity, the role of KIR genes in transplantation remains to be further investigated. In this study, we have evaluated whether KIR genotype differences between donors and recipients of HLA identical (related and unrelated) compared with HLA non-identical unrelated BMT, had an impact on transplantation outcome. Our results show that 5 of 15 KIR genes were always identical in donors and recipients and most variations were observed in the number and specificity of noninhibitory KIR genes. Based on the presence or absence of particular KIR genes, 70 different genotypes were obtained from all individuals. According to the donor or recipient KIR genotype, different combination patterns were described. Interestingly, when the recipient KIR genotype was "included" in the donor KIR genotype, 100% (11/11 pairs) of unrelated BMT developed GVHD compared with 60% (18/30) in all other combinations (p = 0.012). In contrast, no GVHD was observed in related BMT when the recipient KIR genotype was "included" in the donor KIR genotype (p = 0.0001). In conclusion, our results reveal a great diversity for KIR genotypes in donors and recipients of BMT and that the risk of GVHD was maximum in unrelated BMT when the recipient KIR genotype was "included" in the donor KIR genotype.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12039408     DOI: 10.1016/s0198-8859(02)00373-7

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  34 in total

Review 1.  Progress in haploidentical stem cell transplantation.

Authors:  Ulas D Bayraktar; Richard E Champlin; Stefan O Ciurea
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-09       Impact factor: 5.742

Review 2.  Hematopoietic SCT from partially HLA-mismatched (HLA-haploidentical) related donors.

Authors:  H J Symons; E J Fuchs
Journal:  Bone Marrow Transplant       Date:  2008-08-04       Impact factor: 5.483

Review 3.  Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies.

Authors:  Stefan O Ciurea; Richard E Champlin
Journal:  Biol Blood Marrow Transplant       Date:  2012-08-11       Impact factor: 5.742

4.  Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation.

Authors:  Rafijul Bari; Piya Rujkijyanont; Erin Sullivan; Guolian Kang; Victoria Turner; Kwan Gan; Wing Leung
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

5.  Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.

Authors:  Heather J Symons; M Sue Leffell; Nancy D Rossiter; Marianna Zahurak; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-02       Impact factor: 5.742

6.  The diversity of KIR gene in Chinese Northern Han population and the impact of donor KIR and patient HLA genotypes on outcome following HLA-identical sibling allogeneic hematopoietic stem cell transplantation for hematological malignancy in Chinese people.

Authors:  Li Ping Dou; De Hua Zheng; Chang Wang; Jun Hua Liu; Jing Fen Sun; Hai Jie Jin; Chun Ji Gao; Li Yu; Wan Ming Da
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

7.  Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia.

Authors:  Vanderson Rocha; Annalisa Ruggeri; Stephen Spellman; Tao Wang; Ronald Sobecks; Franco Locatelli; Medhat Askar; Gerard Michel; William Arcese; Anna Paola Iori; Duncan Purtill; Robert Danby; Guillermo F Sanz; Eliane Gluckman; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2016-04-16       Impact factor: 5.742

8.  Use of natural killer cells as immunotherapy for leukaemia.

Authors:  Bartosz Grzywacz; Jeffrey S Miller; Michael R Verneris
Journal:  Best Pract Res Clin Haematol       Date:  2008-09       Impact factor: 3.020

9.  Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.

Authors:  Karina L McQueen; Kristel M Dorighi; Lisbeth A Guethlein; Ruby Wong; Bharati Sanjanwala; Peter Parham
Journal:  Hum Immunol       Date:  2007-03-12       Impact factor: 2.850

10.  High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles.

Authors:  Kathleen A Houtchens; Robert J Nichols; Martha B Ladner; Hannah E Boal; Cristina Sollars; Daniel E Geraghty; Lee M Davis; Peter Parham; Elizabeth A Trachtenberg
Journal:  Immunogenetics       Date:  2007-04-27       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.